The Strom Law Firm is now investigating and evaluating potential cases against Samsca. The FDA issued a Drug Safety Communication Tuesday, April 30, 2013. The safety announcement notes that Samsca should not be used for any longer than 30 days and should not be used in those with an underlying liver disease as it can cause liver injury that may potentially require liver transplant or cause death. Samsca is a drug used to treat low sodium levels in blood. Recent clinical trials showed an increased risk of liver injury when evaluating … [Read more...]
You are here: Home / Archives for Samsca Safety Advisory
Samsca Safety Alert
May 2, 2013 By Pete Strom
Filed Under: SC Personal Injury Attorneys Blog Tagged With: ADPKD, autosomal dominant polycystic kidney disease, FDA Drug Safety Advisory for Samsca, Liver Disease, Liver Failure, Otsuka American Pharmaceutical Inc., Pete Strom, Samsca Safety Advisory, SC Defective Drug Attorney, SC Defective Drug Lawyer, SC Personal Injury Attorney, SC Personal Injury Lawyer, The Strom Law Firm
